Abstract:Severe hearing loss or deafness is often caused by cochlear hair cell loss and can be mitigated by a cochlear implant (CI). CIs target the auditory nerve, consisting of spiral ganglion cells (SGCs), which degenerate gradually, following hair cell loss. In animal models, it has been established that treatment with the neurotrophins brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) reduce SGC degeneration. In this study, we aimed to investigate whether treatment with both BDNF and NT-3 (Cocktail) is superior to treatment with each neurotrophin separately regarding cell preservation and neural responsiveness to electrical stimulation. To this end, deafened guinea pigs received neurotrophic treatment in their right ear via a gelatin sponge on the perforated round window membrane, followed by cochlear implantation 4 weeks later in the same ear for electrophysiological recordings to various stimulation paradigms. Normal-hearing and deafened untreated guinea pigs were included as positive and negative controls, respectively. Substantial SGC loss occurred in all deafened animals. Each of the neurotrophic treatments led to enhanced SGC survival mainly in the basal turn of the cochlea, gradually decreasing toward the apex. The Cocktail treatment resulted in the highest SGC survival in the treated ear, followed by BDNF, with the least protection of SGCs following NT-3 treatment. Survival of the SGC's peripheral processes (PPs) followed the same trend in response to the treatment. However, survival of SGCs and PPs in the contralateral untreated ears was also highest in the Cocktail group. Consequently, analysis of the ratio between the treated and untreated ears showed that the BDNF group, which showed low SGC survival in the untreated ear, had the highest relative SGC survival of the three neurotrophin-treated groups. Neurotrophic treatment had positive effects in part of the electrically evoked compound action-potential recording paradigms. These effects were only observed for the BDNF or Cocktail treatment. We conclude that treatment with either BDNF or a cocktail of BDNF and NT-3 is preferred to NT-3 alone. Furthermore, since the Cocktail treatment resulted in better electrophysiological responsiveness and overall higher SGC survival than BDNF alone, we are inclined to recommend the Cocktail treatment rather than BDNF alone.

[Expression of Brain-Derived Neurotrophic Factor Modified Bone Marrow Mesenchymal Stem Cells in the Cochlea of Drug Deafened Guinea Pigs and Its Protection Role].

[Effect of brain-derived neurotrophic factor gene transfected bone-marrow mesenchymal stem cells on damaged cochlear spiral ganglion cells of guinea pigs]

A Preliminary Study of Brain-Derived Neurotrophic Factor Gene Transfected Bone-Marrow Mesenchymal Stem Cells Transplartafion Damaged Cochlea

[Experimental Study on Embryonic Neural Stem Cells Transplantation into Natural Rat Cochlea Via Round Window].

Study on neural stem cell transplantation into natural rat cochlea via round window.

Neural-induced human mesenchymal stem cells promote cochlear cell regeneration in deaf Guinea pigs

No Protective Effects of Hair Cells or Supporting Cells in Ototoxically Deafened Guinea Pigs upon Administration of BDNF

BDNF-mediated preservation of spiral ganglion cell peripheral processes and axons in comparison to that of their cell bodies

mTOR Signaling in BDNF-Treated Guinea Pigs after Ototoxic Deafening

Protective Role of Glial Cell Line-Derived Neurotrophic Factor Following Ototoxic

Transplantation of neural differentiated human mesenchymal stem cells into the cochlea of an auditory-neuropathy guinea pig model

Delayed BDNF application in induced deafness in rats

Combined brain-derived neurotrophic factor and neurotrophin-3 treatment is preferred over either one separately in the preservation of the auditory nerve in deafened guinea pigs

Exogenous IL-4-expressing Bone Marrow Mesenchymal Stem Cells for the Treatment of Autoimmune Sensorineural Hearing Loss in a Guinea Pig Model.

BDNF-enriched Small Extracellular Vesicles Protect Against Noise-Induced Hearing Loss in Mice.

Therapeutic Value of Nerve Growth Factor in Promoting Neural Stem Cell Survival and Differentiation and Protecting Against Neuronal Hearing Loss

Intratympanic injection of MSC-derived small extracellular vesicles protects spiral ganglion neurons from degeneration

Construction of Human Brain-Derived Neurotrophic Factor Genetical Modified Marrow Stromal Cells and Its Influence on the Cultured Spiral Ganglion Cells of Mice

The Hearing Protection of NGF to Mimetic Aging Guinea Pigs

Ginkgo Biloba Extract Enhances Differentiation and Performance of Neural Stem Cells in Mouse Cochlea

Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.